JP2009527463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527463A5 JP2009527463A5 JP2008550463A JP2008550463A JP2009527463A5 JP 2009527463 A5 JP2009527463 A5 JP 2009527463A5 JP 2008550463 A JP2008550463 A JP 2008550463A JP 2008550463 A JP2008550463 A JP 2008550463A JP 2009527463 A5 JP2009527463 A5 JP 2009527463A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- alkyl
- cancer
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 206010001019 Acute promyelocytic leukaemia Diseases 0.000 claims 1
- 210000000601 Blood Cells Anatomy 0.000 claims 1
- 210000001185 Bone Marrow Anatomy 0.000 claims 1
- 210000000988 Bone and Bones Anatomy 0.000 claims 1
- 210000004556 Brain Anatomy 0.000 claims 1
- 210000000481 Breast Anatomy 0.000 claims 1
- 210000003169 Central Nervous System Anatomy 0.000 claims 1
- 210000001072 Colon Anatomy 0.000 claims 1
- 210000004696 Endometrium Anatomy 0.000 claims 1
- 210000003238 Esophagus Anatomy 0.000 claims 1
- 210000003128 Head Anatomy 0.000 claims 1
- 210000003734 Kidney Anatomy 0.000 claims 1
- 206010024324 Leukaemias Diseases 0.000 claims 1
- 208000005749 Leukemia, Promyelocytic, Acute Diseases 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 210000001165 Lymph Nodes Anatomy 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010028576 Myeloproliferative disease Diseases 0.000 claims 1
- 210000003739 Neck Anatomy 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010025310 Other lymphomas Diseases 0.000 claims 1
- 210000001672 Ovary Anatomy 0.000 claims 1
- 210000000496 Pancreas Anatomy 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 210000002307 Prostate Anatomy 0.000 claims 1
- 208000009527 Refractory Anemia Diseases 0.000 claims 1
- 206010072684 Refractory cytopenia with unilineage dysplasia Diseases 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 210000000952 Spleen Anatomy 0.000 claims 1
- 210000002784 Stomach Anatomy 0.000 claims 1
- 210000001550 Testis Anatomy 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 201000009251 multiple myeloma Diseases 0.000 claims 1
- 201000003793 myelodysplastic syndrome Diseases 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75921806P | 2006-01-13 | 2006-01-13 | |
US60/759,218 | 2006-01-13 | ||
US76300806P | 2006-01-26 | 2006-01-26 | |
US60/763,008 | 2006-01-26 | ||
PCT/US2007/001127 WO2007082104A2 (en) | 2006-01-13 | 2007-01-16 | Compounds and methods for the treatment of cancer |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009527463A JP2009527463A (ja) | 2009-07-30 |
JP2009527463A5 true JP2009527463A5 (US20040106767A1-20040603-C00005.png) | 2010-03-04 |
JP5202332B2 JP5202332B2 (ja) | 2013-06-05 |
Family
ID=38158019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008550463A Expired - Fee Related JP5202332B2 (ja) | 2006-01-13 | 2007-01-16 | がんの治療のための化合物および方法 |
Country Status (10)
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0821002A2 (pt) * | 2007-12-12 | 2015-06-16 | Ziopharm Oncology Inc | Compostos e métodos para o tratamento de câncer |
DK3388111T3 (da) * | 2008-08-20 | 2021-12-06 | Solasia Pharma K K | Organoarsenforbindelse til behandlingen af kræft |
KR20160086960A (ko) * | 2013-12-05 | 2016-07-20 | 솔레이지아 파마 가부시키가이샤 | 암 치료를 위한 화합물 및 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1964557B1 (en) | 1997-11-10 | 2013-01-02 | Memorial Sloan-Kettering Cancer Center | Process for producing arsenic trioxide formulations |
EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
WO2003057012A2 (en) * | 2002-01-07 | 2003-07-17 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
TW201440760A (zh) * | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
-
2007
- 2007-01-16 WO PCT/US2007/001127 patent/WO2007082104A2/en active Application Filing
- 2007-01-16 AU AU2007204831A patent/AU2007204831B2/en not_active Ceased
- 2007-01-16 US US12/087,682 patent/US8222440B2/en not_active Expired - Fee Related
- 2007-01-16 CN CN201410253092.4A patent/CN104109177A/zh active Pending
- 2007-01-16 KR KR1020137029751A patent/KR20130129316A/ko not_active Application Discontinuation
- 2007-01-16 EP EP07717781.4A patent/EP1979368B1/en active Active
- 2007-01-16 CN CN200780007370.6A patent/CN101395166B/zh not_active Expired - Fee Related
- 2007-01-16 CA CA2636793A patent/CA2636793C/en active Active
- 2007-01-16 JP JP2008550463A patent/JP5202332B2/ja not_active Expired - Fee Related
-
2008
- 2008-07-09 IL IL192738A patent/IL192738A0/en unknown
- 2008-08-08 KR KR1020087019499A patent/KR101471498B1/ko active IP Right Grant
-
2009
- 2009-09-25 HK HK09108874.5A patent/HK1130804A1/xx not_active IP Right Cessation
- 2009-09-25 HK HK15103803.4A patent/HK1203512A1/xx unknown
-
2012
- 2012-07-03 US US13/541,288 patent/US20130143950A1/en not_active Abandoned
-
2013
- 2013-05-16 IL IL226362A patent/IL226362A0/en unknown
- 2013-05-16 IL IL226363A patent/IL226363A0/en unknown